• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估一个在种族多样化数据集上训练的人工智能算法,以对一个以前未见过的人群进行糖尿病视网膜病变筛查。

Evaluation of an AI algorithm trained on an ethnically diverse dataset to screen a previously unseen population for diabetic retinopathy.

机构信息

AL& ML, Remidio Innovative Solutions, Inc, Glen Allen, USA.

AI&ML, Medios Technologies Pte Ltd, Remidio Innovative Solutions, Singapore.

出版信息

Indian J Ophthalmol. 2024 Aug 1;72(8):1162-1167. doi: 10.4103/IJO.IJO_2151_23. Epub 2024 Jul 29.

DOI:10.4103/IJO.IJO_2151_23
PMID:39078960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11451790/
Abstract

PURPOSE

This study aimed to determine the generalizability of an artificial intelligence (AI) algorithm trained on an ethnically diverse dataset to screen for referable diabetic retinopathy (RDR) in the Armenian population unseen during AI development.

METHODS

This study comprised 550 patients with diabetes mellitus visiting the polyclinics of Armenia over 10 months requiring diabetic retinopathy (DR) screening. The Medios AI-DR algorithm was developed using a robust, diverse, ethnically balanced dataset with no inherent bias and deployed offline on a smartphone-based fundus camera. The algorithm here analyzed the retinal images captured using the target device for the presence of RDR (i.e., moderate non-proliferative diabetic retinopathy (NPDR) and/or clinically significant diabetic macular edema (CSDME) or more severe disease) and sight-threatening DR (STDR, i.e., severe NPDR and/or CSDME or more severe disease). The results compared the AI output to a consensus or majority image grading of three expert graders according to the International Clinical Diabetic Retinopathy severity scale.

RESULTS

On 478 subjects included in the analysis, the algorithm achieved a high classification sensitivity of 95.30% (95% CI: 91.9%-98.7%) and a specificity of 83.89% (95% CI: 79.9%-87.9%) for the detection of RDR. The sensitivity for STDR detection was 100%.

CONCLUSION

The study proved that Medios AI-DR algorithm yields good accuracy in screening for RDR in the Armenian population. In our literature search, this is the only smartphone-based, offline AI model validated in different populations.

摘要

目的

本研究旨在确定在人工智能(AI)算法开发过程中未见过的亚美尼亚人群中,针对糖尿病性视网膜病变(DR)进行筛查,该算法是在一个种族多样化的数据集上进行训练的,以确定其是否具有普遍性。

方法

本研究纳入了 10 个月内在亚美尼亚多家诊所就诊的 550 名糖尿病患者,这些患者需要进行 DR 筛查。使用一个稳健、多样化、种族平衡的数据集,没有内在偏见,开发了 Medios AI-DR 算法,该算法在基于智能手机的眼底相机上离线运行。该算法分析了使用目标设备拍摄的视网膜图像,以确定是否存在 RDR(即中度非增生性糖尿病性视网膜病变(NPDR)和/或临床显著糖尿病性黄斑水肿(CSDME)或更严重的疾病)和威胁视力的 DR(STDR,即严重 NPDR 和/或 CSDME 或更严重的疾病)。结果将 AI 输出与三位专家根据国际临床糖尿病视网膜病变严重程度标准的共识或多数图像分级进行了比较。

结果

在纳入分析的 478 名患者中,该算法对 RDR 的检测具有较高的分类灵敏度 95.30%(95%CI:91.9%-98.7%)和特异性 83.89%(95%CI:79.9%-87.9%)。STDR 的检测灵敏度为 100%。

结论

该研究证明了 Medios AI-DR 算法在亚美尼亚人群中对 RDR 的筛查具有良好的准确性。在我们的文献检索中,这是唯一在不同人群中得到验证的基于智能手机的离线 AI 模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7675/11451790/e9eae60a560d/IJO-72-1162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7675/11451790/05329e3fd578/IJO-72-1162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7675/11451790/e9eae60a560d/IJO-72-1162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7675/11451790/05329e3fd578/IJO-72-1162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7675/11451790/e9eae60a560d/IJO-72-1162-g002.jpg

相似文献

1
Evaluation of an AI algorithm trained on an ethnically diverse dataset to screen a previously unseen population for diabetic retinopathy.评估一个在种族多样化数据集上训练的人工智能算法,以对一个以前未见过的人群进行糖尿病视网膜病变筛查。
Indian J Ophthalmol. 2024 Aug 1;72(8):1162-1167. doi: 10.4103/IJO.IJO_2151_23. Epub 2024 Jul 29.
2
Diagnostic Accuracy of Automated Diabetic Retinopathy Image Assessment Softwares: IDx-DR and Medios Artificial Intelligence.自动化糖尿病视网膜病变图像评估软件的诊断准确性:IDx-DR 和 Medios 人工智能。
Ophthalmic Res. 2023;66(1):1286-1292. doi: 10.1159/000534098. Epub 2023 Sep 27.
3
Medios- An offline, smartphone-based artificial intelligence algorithm for the diagnosis of diabetic retinopathy.基于智能手机的离线人工智能算法 Medios 可用于诊断糖尿病性视网膜病变。
Indian J Ophthalmol. 2020 Feb;68(2):391-395. doi: 10.4103/ijo.IJO_1203_19.
4
Towards a Device Agnostic AI for Diabetic Retinopathy Screening: An External Validation Study.迈向用于糖尿病视网膜病变筛查的设备无关人工智能:一项外部验证研究。
Clin Ophthalmol. 2022 Aug 17;16:2659-2667. doi: 10.2147/OPTH.S369675. eCollection 2022.
5
Validation of Deep Convolutional Neural Network-based algorithm for detection of diabetic retinopathy - Artificial intelligence versus clinician for screening.基于深度卷积神经网络的糖尿病视网膜病变检测算法的验证 - 人工智能与临床医生用于筛查的比较。
Indian J Ophthalmol. 2020 Feb;68(2):398-405. doi: 10.4103/ijo.IJO_966_19.
6
Comparison of 21 artificial intelligence algorithms in automated diabetic retinopathy screening using handheld fundus camera.比较使用手持眼底相机的 21 种人工智能算法在自动化糖尿病性视网膜病变筛查中的应用。
Ann Med. 2024 Dec;56(1):2352018. doi: 10.1080/07853890.2024.2352018. Epub 2024 May 13.
7
Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study.人工智能利用深度学习在非洲筛查可转诊和威胁视力的糖尿病视网膜病变:一项临床验证研究。
Lancet Digit Health. 2019 May;1(1):e35-e44. doi: 10.1016/S2589-7500(19)30004-4. Epub 2019 May 2.
8
Use of offline artificial intelligence in a smartphone-based fundus camera for community screening of diabetic retinopathy.基于智能手机的眼底相机在社区糖尿病视网膜病变筛查中应用离线人工智能。
Indian J Ophthalmol. 2021 Nov;69(11):3150-3154. doi: 10.4103/ijo.IJO_3808_20.
9
Evaluating the efficacy of AI systems in diabetic retinopathy detection: A comparative analysis of Mona DR and IDx-DR.评估人工智能系统在糖尿病视网膜病变检测中的疗效:Mona DR与IDx-DR的比较分析。
Acta Ophthalmol. 2025 Jun;103(4):388-395. doi: 10.1111/aos.17428. Epub 2024 Dec 10.
10
Evaluation of a novel artificial intelligence-based screening system for diabetic retinopathy in community of China: a real-world study.基于人工智能的新型糖尿病视网膜病变筛查系统在中国社区的评估:一项真实世界研究。
Int Ophthalmol. 2021 Apr;41(4):1291-1299. doi: 10.1007/s10792-020-01685-x. Epub 2021 Jan 3.

引用本文的文献

1
Code-Free Machine Learning for the Detection of Common Ophthalmic Diseases.用于常见眼科疾病检测的无代码机器学习
Transl Vis Sci Technol. 2025 Sep 2;14(9):16. doi: 10.1167/tvst.14.9.16.
2
Advancing AMD screening with an offline, AI-powered smartphone-based fundus camera: A prospective, real-world clinical validation.使用基于人工智能的离线智能手机眼底相机推进年龄相关性黄斑变性筛查:一项前瞻性、真实世界的临床验证。
Eye (Lond). 2025 Jul 11. doi: 10.1038/s41433-025-03902-2.
3
Artificial intelligence in ophthalmology: opportunities, challenges, and ethical considerations.

本文引用的文献

1
Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy.自主检测可转诊和威胁视力的糖尿病视网膜病变的人工智能系统的关键性评估。
JAMA Netw Open. 2021 Nov 1;4(11):e2134254. doi: 10.1001/jamanetworkopen.2021.34254.
2
Addressing Artificial Intelligence Bias in Retinal Diagnostics.解决视网膜诊断中的人工智能偏见问题。
Transl Vis Sci Technol. 2021 Feb 5;10(2):13. doi: 10.1167/tvst.10.2.13.
3
Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study.
眼科领域的人工智能:机遇、挑战与伦理考量。
Med Hypothesis Discov Innov Ophthalmol. 2025 May 10;14(1):255-272. doi: 10.51329/mehdiophthal1517. eCollection 2025 Spring.
4
SMART (artificial intelligence enabled) DROP (diabetic retinopathy outcomes and pathways): Study protocol for diabetic retinopathy management.SMART(启用人工智能的)DROP(糖尿病视网膜病变结局与路径):糖尿病视网膜病变管理研究方案
PLoS One. 2025 May 19;20(5):e0324382. doi: 10.1371/journal.pone.0324382. eCollection 2025.
人工智能利用深度学习在非洲筛查可转诊和威胁视力的糖尿病视网膜病变:一项临床验证研究。
Lancet Digit Health. 2019 May;1(1):e35-e44. doi: 10.1016/S2589-7500(19)30004-4. Epub 2019 May 2.
4
The Evolution of Diabetic Retinopathy Screening Programmes: A Chronology of Retinal Photography from 35 mm Slides to Artificial Intelligence.糖尿病视网膜病变筛查项目的演变:从35毫米幻灯片到人工智能的视网膜摄影年表
Clin Ophthalmol. 2020 Jul 20;14:2021-2035. doi: 10.2147/OPTH.S261629. eCollection 2020.
5
Technical and imaging factors influencing performance of deep learning systems for diabetic retinopathy.影响糖尿病视网膜病变深度学习系统性能的技术和成像因素。
NPJ Digit Med. 2020 Mar 23;3:40. doi: 10.1038/s41746-020-0247-1. eCollection 2020.
6
Simple, Mobile-based Artificial Intelligence Algoithm in the detection of Diabetic Retinopathy (SMART) study.基于移动设备的糖尿病视网膜病变检测简易人工智能算法(SMART)研究
BMJ Open Diabetes Res Care. 2020 Jan;8(1). doi: 10.1136/bmjdrc-2019-000892.
7
Medios- An offline, smartphone-based artificial intelligence algorithm for the diagnosis of diabetic retinopathy.基于智能手机的离线人工智能算法 Medios 可用于诊断糖尿病性视网膜病变。
Indian J Ophthalmol. 2020 Feb;68(2):391-395. doi: 10.4103/ijo.IJO_1203_19.
8
IDF Diabetes Atlas: A review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018.国际糖尿病联盟糖尿病地图集:对 2015 年至 2018 年期间利用视网膜摄影评估全球糖尿病相关视网膜病变患病率的研究的综述。
Diabetes Res Clin Pract. 2019 Nov;157:107840. doi: 10.1016/j.diabres.2019.107840. Epub 2019 Nov 14.
9
Diagnostic Accuracy of Community-Based Diabetic Retinopathy Screening With an Offline Artificial Intelligence System on a Smartphone.基于智能手机离线人工智能系统的社区糖尿病视网膜病变筛查的诊断准确性
JAMA Ophthalmol. 2019 Oct 1;137(10):1182-1188. doi: 10.1001/jamaophthalmol.2019.2923.
10
Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices.在基层医疗诊所中用于检测糖尿病视网膜病变的基于人工智能的自主诊断系统的关键试验。
NPJ Digit Med. 2018 Aug 28;1:39. doi: 10.1038/s41746-018-0040-6. eCollection 2018.